APA (7th ed.) Citation

S, M., J, B., M, N., H, L., MC, T., A, C., . . . J, T. (2024). Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127. Science (New York, N.Y.), 383(6682), eadi5798. https://doi.org/10.1126/science.adi5798

Chicago Style (17th ed.) Citation

S, Montoya, et al. "Kinase-impaired BTK Mutations Are Susceptible to Clinical-stage BTK and IKZF1/3 Degrader NX-2127." Science (New York, N.Y.) 383, no. 6682 (2024): eadi5798. https://doi.org/10.1126/science.adi5798.

MLA (9th ed.) Citation

S, Montoya, et al. "Kinase-impaired BTK Mutations Are Susceptible to Clinical-stage BTK and IKZF1/3 Degrader NX-2127." Science (New York, N.Y.), vol. 383, no. 6682, 2024, p. eadi5798, https://doi.org/10.1126/science.adi5798.